Laura Martin de la Fuente – Research output — Lund University

Phone+46762706599, +4646175817
Emaillaura.martin_de_la_fuentemed.luse

8 Article
2 Poster
1 Doctoral Thesis (compilation)

8 results

Filter

2021
MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer
Bååth, M., Jönsson, J-M., Westbom Fremer, S., Martin de la Fuente, L., Tran, L., Malander, S., Kannisto, P., Måsbäck, A., Honeth, G. & Hedenfalk, I., 2021 May 14, In: Genes. 12, 5, 742.
Research output: Contribution to journal › Article › peer-review

Open Access
2020
High density of stroma-localized CD11c-positive macrophages is associated with longer overall survival in high-grade serous ovarian cancer
Corvigno, S., Mezheyeuski, A., De La Fuente, L. M., Westbom-Fremer, S., Carlson, J. W., Fernebro, J., Åvall-Lundqvist, E., Kannisto, P., Hedenfalk, I., Malander, S., Rolny, C., Dahlstrand, H. & Östman, A., 2020 Dec 1, In: Gynecologic Oncology. 159, 3, p. 860-868 9 p.
Research output: Contribution to journal › Article › peer-review
SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery
Bååth, M., Westbom-Fremer, S., Martin de la Fuente, L., Ebbesson, A., Davis, J., Malander, S., Måsbäck, A., Kannisto, P. & Hedenfalk, I., 2020 Sept, In: Molecular and Cellular Oncology. 7, 6, 1805094.
Research output: Contribution to journal › Article › peer-review

Open Access
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
Martin de la Fuente, L., Westbom-Fremer, S., Arildsen, N. S., Hartman, L., Malander, S., Kannisto, P., Måsbäck, A. & Hedenfalk, I., 2020 Jul, In: Virchows Archiv: an international journal of pathology. 477, 1, p. 83-91 9 p.
Research output: Contribution to journal › Article › peer-review

Open Access
2019
Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method
Arildsen, N. S., Martin de la Fuente, L., Måsbäck, A., Malander, S., Forslund, O., Kannisto, P. & Hedenfalk, I., 2019 Oct 29, In: Scientific Reports. 9, 1, p. 1-8 15506.
Research output: Contribution to journal › Article › peer-review

Open Access
A targeted mass spectrometry strategy for developing proteomic biomarkers: a case study of epithelial ovarian cancer
Huttenhain, R., Choi, M., Martin de la Fuente, L., Oehl, K., Chang, C-Y., Zimmermann, A-K., Malander, S., Olsson, H., Surinova, S., Clough, T., Heinzelmann-Schwarz, V., Wild, P. J., Dinulescu, D., Niméus, E., Vitek, O. & Aebersold, R., 2019, In: Molecular and Cellular Proteomics. 18, 9, p. 1836-1850
Research output: Contribution to journal › Article › peer-review
2018
Claudin-4 Expression is Associated with Survival in Ovarian Cancer but Not with Chemotherapy Response
Martín De La Fuente, L., Malander, S., Hartman, L., Jönsson, J. M., Ebbesson, A., Nilbert, M., Måsbäck, A. & Hedenfalk, I., 2018, In: International Journal of Gynecological Pathology. 37, 2, p. 101-109
Research output: Contribution to journal › Article › peer-review
2017
Claudin-4 expression is associated with progression free survival in ovarian cancer, but not with chemotherapy response
Martin de la Fuente, L., Malander, S., Hartman, L., Jönsson, J-M., Ebbesson, A., Nilbert, M., Måsbäck, A. & Hedenfalk, I., 2017, In: International Journal of Gynecological Pathology. 37, 2, p. 101-109
Research output: Contribution to journal › Article › peer-review

Open Access